Exit
In order to receive credit for this activity, you must read the front matter, view the activity, complete the post-survey, as well as complete the linked evaluation and application for credit form. Certificates of credit will be emailed to participants who have successfully met these requirements. 

There is no fee to participate in this activity.

Question Title

* 1. Where are you in your career?

Question Title

* 2. The risk of major adverse cardiovascular event (MACE) increased with tofacitinib compared to anti-TNF at 4 years in patients above age 50 with one cardiovascular risk factors (smoking, high blood pressure), with which chronic disease?

Question Title

* 3. Which class(es) of drugs have been shown to be as effective in patients with ulcerative colitis who were previously exposed to IFX than in patients who were bio-naïve?

EVALUATION FORM

Question Title

* 4. Based on what I learned today, I will improve my practice by incorporating the following in my care of patients with IBD (check all that apply):

Question Title

* 5. Upon completion of this activity, I am able to:

  Strongly agree Agree Disagree Strongly disagree
IDENTIFY guideline-directed strategies and best practices for the care of patients with IBD
ANALYZE potential approaches for positioning new and emerging therapies for UC
EVALUATE complex clinical situations in which patients with IBD may benefit from management strategies including novel therapeutics

Question Title

* 6. Please indicate the extent of your agreement with the following statements:

  Strongly agree Agree Disagree Strongly disagree
The faculty for this activity were effective
The educational resources and/or handouts provided to me at the educational activity are useful to my practice

Question Title

* 7. Overall, was this activity fair, balanced and free from commercial bias?

Question Title

* 8. If no, please explain:

Question Title

* 9. Of the patients you will see in the next month, about how many will benefit from the information you learned today?

Question Title

* 10. I will make the following changes to my practice based on what I learned today (check all that apply):

Question Title

* 11. Based on your experience, which of the following are the primary barriers to implementing changes in practice (check all that apply):

Question Title

* 12. For purposes of certification, please complete the following information. *Please note that we will not forward or sell your contact information.*

Question Title

* 13. I certify that I have participated in the continuing education activity entitled, "MondayNightIBD | UC Refractory to TNFi - Considerations for Next Therapies" and claim 1.0 AMA PRA Category 1 CreditTM.

Thank you for participating in our activity and completing the necessary paperwork. Your certificate will be emailed to you using the email address provided above. Please allow 4 weeks to receive your certificate. 

For information about the certification of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.
( Privacy & Cookie Notice

T